Back to Journals » Therapeutics and Clinical Risk Management » Volume 12

New treatment options for ALK+ advanced non-small-cell lung cancer: critical appraisal of ceritinib

Total article views   Abstract views HTML views PDF downloads Totals
12,352 Dovepress* 10,439 929+ 1,197 11,368
PubMed Central* 0 984 316 984
Totals 10,439 1,913 1,513 12,352
*Since 5 May 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
18 0 0 1 8 9

View citations on PubMed Central and Google Scholar